Orion Corporation

From Wikipedia, the free encyclopedia
Jump to: navigation, search
This article is about the pharmaceutical company. For other companies named Orion, see Orion (disambiguation).
Orion Oyj
Julkinen osakeyhtiö
Traded as Nasdaq HelsinkiORNBV
Industry Pharmaceutical industry
Founded 1917
Headquarters Espoo, Finland
Key people
Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman)
Products Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests
Revenue Increase €1.016 billion (2015)[1]
Decrease €267 million (2015)[1]
Profit Decrease €208 million (2015)[1]
Total assets Increase €1.047 billion (2015)[1]
Total equity Increase €595 million (2015)[1]
Number of employees
Decrease 3,401 (2015)[1]
Website www.orion.fi

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.

Orion's class A and B shares are listed on the Helsinki Stock Exchange.

Products[edit]

  • Cardiovascular drugs

References[edit]

External links[edit]